Ultraviolet spectrophotometric analysis of barbiturates: evaluation of potential interferences.
D000082:Acetaminophen / Q000097:blood; D001463:Barbiturates / Q000097:blood*; D002740:Chlorothiazide / Q000097:blood; D002747:Chlorpropamide / Q000097:blood; D001728:Dicumarol / Q000097:blood; D006801:Humans; D008722:Methods; D009539:Nicotinic Acids / Q000097:blood; D010113:Oxyphenbutazone / Q000097:blood; D010615:Phenacetin / Q000097:blood; D010630:Phenindione / Q000097:blood; D010634:Phenobarbital / Q000097:blood; D010653:Phenylbutazone / Q000097:blood; D010672:Phenytoin / Q000097:blood; D012459:Salicylates / Q000097:blood; D013056:Spectrophotometry, Ultraviolet; D013420:Sulfamethoxazole / Q000097:blood; D013442:Sulfinpyrazone / Q000097:blood; D013444:Sulfisoxazole / Q000097:blood; D013805:Theobromine / Q000097:blood; D013806:Theophylline / Q000097:blood; D014859:Warfarin / Q000097:blood
D001463:Barbiturates; D009539:Nicotinic Acids; D012459:Salicylates; D000082:Acetaminophen; D010630:Phenindione; D014859:Warfarin; D010672:Phenytoin; D013444:Sulfisoxazole; D002740:Chlorothiazide; D001728:Dicumarol; D013806:Theophylline; D010615:Phenacetin; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D013420:Sulfamethoxazole; D013805:Theobromine; D013442:Sulfinpyrazone; D002747:Chlorpropamide; D010634:Phenobarbital